pharma
England set to adopt opt-out organ donation
October 5, 2017Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical
In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …
Gilead completes £11.9 billion Kite Pharma acquisition
October 5, 2017Sales and Marketing CAR T, CAR-T, Gilead, Kite, acquisition, pharma, pharmaceuticals
Gilead has announced that it has completed its acquisition of Kite Pharma after the deal was announced on 28 August …
57% of cancer drugs uses approved by EMA show no benefit
October 5, 2017Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical
A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …
Mylan receives shock approval of Teva blockbuster
October 5, 2017Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …
AbbVie adds biologic production capability to Singapore facility
October 4, 2017Manufacturing and Production, Research and Development AbbVie, Singapore, biologics, pharma, pharmaceuticals
AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …
CytomX scores deal with Amgen worth potential $1.5bn
October 4, 2017Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical
CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …
Police raid French HQ of Merck KGaA over thyroid drug scandal
October 4, 2017Manufacturing and Production, Research and Development, Sales and Marketing Levothyrox, Merck KGaA, hyperthyroidism, pharma, pharmaceuticals
Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …
Global campaign to reduce cholera deaths by 90%
October 4, 2017Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical
A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …
Shire takes fight to Allergan over dry-eye drug
October 4, 2017Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
NIH funds research into infant opioid withdrawal syndrome treatment
October 3, 2017Manufacturing and Production, Research and Development NIH, National Institutes of Health, opioid crisis, opioids, pharma, pharmaceuticals
As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …
Bavarian Nordic seals $539 million vaccine deal
October 3, 2017Manufacturing and Production BARDA, Bavarian Nordic, biotech, drugs, pharma, pharmaceutical
Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to …
FDA to expedite complex generic approvals to lower drug prices through competition
October 3, 2017Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, FDA, generics, pharma, pharmaceutical
In the midst of ongoing discussions over drug pricing, the FDA has announced plans to facilitate accelerated access to generic …
‘Universal flu vaccine’ to be trialed this winter
October 3, 2017Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …
AstraZeneca Chairman wants three-year Brexit transition period
October 3, 2017Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical
The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …
Collaboration brings forward potential broad flu cure
October 2, 2017Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical
A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
